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SeverityAbstract Objectives: The study investigates the influence of altitude on asthma severity and qual-
ity of life in asthmatic children in southwestern Saudi Arabia.
Methods: Comparative hospital based study was conducted on 90 bronchial asthma patients aged
5–12 years prospectively underwent consultations in pediatric clinics at Maternity and Children
Hospital (MCH) in moderate altitude area and 90 age and sex matched patients during consultation
in pediatric clinics atMCH in lowaltitude area. For both groups, asthma severitywas assessed accord-
ing to GINA 2002 criteria and patients responded pediatric quality of life inventory generic core
scales. Altitude and climatic conditions were abstracted from standardized sources.
Results: Asthma severity was significantly lower in moderate altitude compared to low altitude.
Also, severity of symptoms and need for controller medications were negatively associated with alti-
tude. Inmultiple regression analysis, the physical and psychosocial domains of quality of life were pos-
itively predicted by altitude and negatively with asthma severity.
In conclusion: Moderate altitude was significantly associated with lower degree of asthma disease
severity, lower need for controller medication and better quality of life.
 2016 The Egyptian Society of Chest Diseases and Tuberculosis. Production and hosting by Elsevier B.V.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-
nd/4.0/).Introduction
Bronchial asthma represents one of the prominent heath prob-
lems for all age groups, but especially in children and adoles-
cents due to its wide prevalence, growth of annual
morbidity, frequent complications, as well as evident decline
in work ability and quality of life [1,2]. Typical consequences
of bronchial asthma include; sleep disorders, impaired daily
activity and inability of exercising, lack of sufficient rest, lack
556 A.S. Alsamghan et al.of opportunity to study and work, leading to general quality of
life worsening, increase of both direct and indirect economic
government losses take place [3,4].
The worldwide prevalence of asthma ranges from 1% to
18% [1,5] with nearly 10% of patients suffer from severe dis-
ease, which remains difficult to control despite inhaler therapy
[5]. In Saudi Arabia, it is one of the most common chronic dis-
eases affecting more than 2 million Saudis [6]. The moderniza-
tion of Saudi society, changes in dietary habits, and exposure
to environmental factors, such as indoor allergens, tobacco,
outdoor air pollution, dusts and sand storms may be responsi-
ble for the growing burden of bronchial asthma especially
among children [7].
The most important goal in the management of bronchial
asthma is the maintenance of a normal quality of life for the
patients. The health related quality of life in asthma can be
assessed by either a generic or a disease-specific instrument.
Pediatric quality of life questionnaire is a valid and reliable
tool that could be used to assess the quality of life among asth-
matic children and found to be correlated well with disease
severity [9].
There is a growing concern about the effect of living at
moderate and high altitudes in minimizing asthma severity
and improving asthma control, performance and sense of well-
being [8,10]. This may related to the environmental privileges
of moderate to high-altitude area which is characterized by
dry, clean air, with reduced levels of house dust mites, partic-
ulate matters and molds [10].
The main objective of the current study was to examine
whether living in moderate altitude area minimizes the severity
bronchial asthma disease, need for corticosteroid controller
medication and improves pediatric quality of life compared
with living at low level.
Subjects and methods
A comparative hospital based study was conducted on 180
patients of either gender with different grades of bronchial
asthma. Patients were recruited from outpatient clinics of
Maternity and Children Hospitals in two large cities in the
southwestern Saudi Arabia- Abha and Jizan- during the period
March–September 2015.
Abha town is the capital of Aseer region; it is situated at an
elevation of 2270 m (7500 feet) above sea level and it has a gen-
erally moderate climate, heavy rainfall, green pasture and agri-
cultural plateaus. [11]. Thus, the population in Abha city is
living at moderate altitude climate [12]. The average annual
outdoor annual temperature is 17.5 C and ranges from
12.7 C (in January) to 22.4 C (in June). The relative humidity
typically ranges from 42% to 69% over the course of the year,
rarely dropping below 24%, or exceeding 81% [13].
Jizan town is the capital of Jizan region; it is located to the
west of Abha on the tropical Red Sea coast. It has subtropical
desert, low level arid hot climate. The mean annual tempera-
ture is 29.6 C and ranges from 25 C in January to 33 C in
June. The relative humidity typically ranges from 47% to
85% over the course of the year, rarely dropping below
37%, or exceeding 91% [14].
All asthmatic patients in the age group 5–12 year old who
underwent consultation during the study period to pediatricoutpatient clinics in Maternity and Children Hospital in Abha
and Jazan cities and who agreed to participate in the research
were included in this study. The inclusion criteria include; asth-
matic, age group 5–12 year old and free from other chronic
diseases.
Recruited patients were diagnosed by observing the clinical
findings compatible with bronchial asthma at the physical
examination and classified into four categories: intermittent,
mild persistent, moderate persistent or severe persistent
according to asthma severity (level of symptoms, airflow limi-
tation and lung function variability), taking into account the
treatment dose and following the recommendations of the
GINA 2002 [15].
The patients were subjected to specially designed question-
naire that included questions about; sociodemographic crite-
ria, asthma symptoms (dyspnea, cough and wheezing) during
the previous 4 weeks, current medication, time since diagnosis
of asthma, and history of allergy.
Also, they responded to Arabic version for Pediatric Qual-
ity of Life InventoryTM Generic Core Scales (PedsQL Generic
core scales 4.0) [16] by self-report. Trained research assistants
were available to read the questions for some children in the
5–7 age-group and those who found difficulty in understanding
the items.
The PedsQL 4.0 Generic core scales consist of four scales
divided in 23 items assessing the level of physical and psy-
chosocial functioning of children. Physical functioning consists
of 8 items. Psychosocial functioning is divided into three sub-
scales; emotional, social and school functioning, each consist-
ing of 5 items. The instructions ask for the degree of a problem
each item had been during the previous month. A five point
Likert response scale is used (0 = never a problem, 4 = almost
always a problem). Items are reverse-scored and linearly trans-
formed to a 0–100 scale (0 = 100, 1 = 75, 2 = 50, 3 = 25,
4 = 0), so that higher scores indicate better health related
quality of life. Scale scores are computed as the sum of the
items divided by the number of items answered. It was found
to be valid and reliable to assess quality of life among healthy
and asthmatic children [17,18].
The Arabic version of PedsQL GCS was found to be a valid
and reliable tool to measure the emotional, social, and school
functioning domains of quality of life in pediatric age group
[16].
The study was approved by the Research Committee at the
King Khalid University. Participation in the study was entirely
on voluntary basis after giving written informed consent
signed by child’s parent or his trustee.
Data entry and analysis
Data entry and analyses were done using SPSS, version 22.
Continuous data were presented as mean and standard devia-
tion and compared using Student’s t-test and Mann–Whitney-
U test for parametric and non-parametric data respectively. In
categorical data, the Chi-squared test was used for comparison
between groups. Significant factors predicting the quality of
life on simple linear analysis were entered into multivariate lin-
ear regression analysis to find out the independent predictors
of quality of life. P< 0.05 was considered statistically
significant.
Table 1 Socio-demographic criteria of studied asthmatic patients living in low and moderate altitudes.
Socio-demographic criteria Total N= 180 Altitude P-value
Low altitude N= 90 Moderate altitude N= 90
No. (%) No. (%)
Age (years)
Mean ± SD 9.14 ± 1.43 8.90 ± 1.70 9.42 ± 2.39 0.1
Sex
Male 110(61.1) 59 (65.55) 51 (56.70) 0.22
Female 70 (38.9) 31 (34.45) 39 (43.30)
Residence
Rural 75 (41.7) 34 (37.78) 41 (45.60) 0.29
Urban 105 (58.3) 56 (62.22) 49 (54.40)
Socioeconomic status
High 14 (7.77) 5 (5.55) 9 (10.00) 0.33
Moderate 128 (71.7) 68 (75.55) 60 (66.70)
Low 38 (21.1) 17 (18.88) 21 (23.30)
Father’s work
Professional 26 (14.4) 16 (17.78) 10 (11.10) 0.27
Semi professional 52 (28.9) 27 (30.0) 25 (27.80)
Retired 24 (13.3) 13 (14.44) 11 (12.20)
Military 48 (27.2) 18 (20.0) 30 (33.30)
Other 30 (16.7) 16 (17.78) 14 (15.60)
Father’s education
Less than secondary 65 (36.1) 28 (31.11) 37 (41.10) 0.23
Secondary 67 (37.2) 34 (37.78) 33 (36.70)
More than secondary 48 (26.7) 28 (31.11) 20 (22.20)
Table 2 Influence of altitude on clinical criteria of asthma and scores of pediatric quality of life among patients in low and moderate
altitudes.
Altitude P-value
Low altitude
N= 90 No. (%)
Moderate altitude
N= 90 No. (%)
Disease duration (years) 4.59 ± 1.57 5.14 ± 2.73 0.1
Degree of asthma
Intermittent 30 (33.33) 59 (65.60)
Mild 33(36.66) 23 (25.60) 0.00
Moderate 22 (24.44) 6 (6.70)
Severe 5 (5.55) 2 (2.20)
Asthma symptoms
Cough only 2 (2.22) 15 (16.70)
Cough & wheeze 7 (7.77) 38 (42.20) 0.000
Cough, wheeze & dyspnea 81 (90.0) 37 (41.10)
Allergic asthma 60 (66.66) 57 (63.30) 0.67
Use of controller medications 83 (92.22) 67 (74.44) 0002
Quality of life
Physical 59.34 ± 11.63 68.49 ± 13.73 0.00
Emotional 42.64 ± 10.26 75.33 ± 20.21 0.00
Social 62.2 ± 11.21 86.5 ± 14.27 0.00
School 50.38 ± 9.84 71.83 ± 15.15 0.00
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Table 1 summarizes the demographic data of the low and mod-
erate altitudes asthmatic groups. Both groups were matched
for sociodemographic variables. Patients had an age range of
5–12 years; with an average age of 9.14 ± 1.43 years. The dis-
ease was reported more frequently in male (61.1%), residents
of urban areas (58.3%) and those with moderate socioeco-
nomic standard (71.7%).Influence of altitude on clinical criteria and scores of pedi-
atric quality of life of the studied asthmatic patients are
demonstrated in Table 2. The average disease duration and
history of allergy were matched in both groups. At the time
of follow up, the degree of disease severity was significantly
higher among low altitude (Jizan) patients compared to mod-
erate altitude (Abha) (P< 0.001). Most of patients at low alti-
tude were of mild to moderate degree bronchial asthma (59%),
while at moderate altitude most of them had intermittent
Table 3 Influence of socio-demographic and clinical factors on pediatric quality of life (PQL) scores.
Physical mean ± SD Emotional mean ± SD Social mean ± SD School mean ± SD
Age (years): 6–9 62.15 ± 11.81 59.79 ± 22.561 74.50 ± 18.86 60.21 ± 17.35
9–12 64.99 ± 14.38 58.33 ± 23.153 74.14 ± 16.94 61.58 ± 16.26
p-value 0.17 0.68 0.89 0.59
Residence: rural 62.13 ± 13.59 62.47 ± 23.64 74.33 ± 18.77 62.93 ± 17.22
Urban 65.13 ± 13.34 56.37 ± 22.08 74.25 ± 16.93 59.72 ± 16.20
p-value 0.14 0.08 0.97 0.20
Sex: male 64.14 ± 13.37 59.91 ± 22.71 75.77 ± 16.55 60.90 ± 16.57
Female 63.50 ± 13.75 57.29 ± 23.19 71.93 ± 19.17 61.29 ± 16.91
p-value 0.76 0.45 0.17 0.88
Socioeconomic standard: low 67.32 ± 13.46 62.14 ± 27.58 80.36 ± 18.86 69.29 ± 16.16
Moderate 63.59 ± 13.68 56.71 ± 22.07 73.10 ± 17.03 59.84 ± 16.09
High 63.63 ± 13.01 61.45 ± 22.42 76.05 ± 19.18 62.11 ± 18.18
p-value 0.61 0.64 0.27 0.12
Father’s occupation: professional 64.36 ± 13.93 62.81 ± 21.68 77.81 ± 17.98 65.00 ± 15.68
Semi professional 63.42 ± 13.65 60.10 ± 24.76 74.42 ± 16.85 60.10 ± 16.64
Retired 62.67 ± 13.80 53.75 ± 22.61 72.08 ± 16.48 57.92 ± 16.35
Military 63.94 ± 12.06 57.41 ± 22.63 74.44 ± 17.99 60.56 ± 15.40
Other 64.87 ± 14.25 56.00 ± 21.95 70.00 ± 19.07 59.33 ± 19.33
p-value 0.97 0.5 0.40 0.40
Father’s education: less than secondary 63.68 ± 13.42 61.23 ± 23.57 73.54 ± 19.18 59.15 ± 16.31
Secondary 63.12 ± 12.17 60.90 ± 23.77 77.31 ± 17.54 63.51 ± 16.40
More than secondary 65.21 ± 15.35 53.06 ± 19.92 71.12 ± 15.25 60.20 ± 17.38
p-value 0.70 0.11 0.16 0.29
Degree of asthma: intermittent 69.59 ± 13.11 67.06 ± 23.2 80.44 ± 15.54 68.39 ± 15.41
Mild 62.38 ± 10.26 56.16 ± 20.02 73.39 ± 17.17 56.16 ± 14.65
Moderate 51.57 ± 8.22 40.89 ± 14.6 60.54 ± 16.41 49.64 ± 13.4
Severe 51.93 ± 15.96 47.86 ± 18.9 57.14 ± 8.09 51.43 ± 16.76
p-value 0.000 0.000 0.000 0.000
Allergic asthma 62.36 ± 13.51 56.99 ± 22.26 72.75 ± 17.88 59.62 ± 16.57
Non allergic 66.76 ± 13.07 62.46 ± 23.74 77.14 ± 17.00 63.73 ± 16.60
p-value 0.03 0.13 0.11 0.11
Symptoms: cough only 68.94 ± 14.20 77.06 ± 16.49 86.76 ± 12.37 72.65 ± 13.71
Cough & Wheeze 67.64 ± 15.13 67.78 ± 22.27 81.78 ± 16.55 65.89 ± 17.20
Cough & dyspnea 61.75 ± 12.30 52.94 ± 21.51 69.66 ± 16.96 57.56 ± 15.72
p-value 0.01 0.00 0.00 0.00
Use of controller medication: regular 62.32 ± 14.06 67.60 ± 20.76 77.00 ± 18.32 62.50 ± 17.53
Irregular 62.71 ± 11.85 53.02 ± 20.71 70.74 ± 16.62 57.18 ± 15.06
p-value 0.85 0.00 0.04 0.05
Follow up: regular 63.20 ± 14.68 65.76 ± 24.76 75.45 ± 19.43 63.48 ± 20.21
On need 64.28 ± 12.80 54.96 ± 20.82 73.61 ± 16.62 59.65 ± 14.138
p-value 0.60 0.002 0.50 0.14
558 A.S. Alsamghan et al.asthma (65.6%). Also, the severity of asthma symptoms was
significantly higher among residents of low altitude
(P< 0.001). Complaining of dyspnea was reported more fre-
quently among patients living at low altitude (90%) compared
to patients living at moderate altitude (41.1%). Moreover,
need for controller medication was significantly higher among
low altitude asthmatic patients (92.2%) compared to those liv-
ing at moderate altitude (74.44%). The scores of different
domains of PedsQL were significantly higher among moderate
altitude patients compared to those living at low level.
Influence of socio-demographic and clinical criteria on
scores of pediatric quality of life of the studied asthmatic
patients are shown in Table 3. Age, sex, residence, socioeco-
nomic standards, father’s education, and father’s work were
insignificantly associated with pediatric quality of life scores.
Different quality of life scores was significantly diminished
with degree of asthma, severity of symptoms and irregular
use of controller medications, altitude, degree of asthma sever-
ity and history of allergy. Meanwhile, physical score was sig-
nificantly diminished in allergic asthma and emotional scorewas significantly decreased in patients with on need follow
up only (Table 3).
The independent predictors of pediatric quality of life
scores as revealed by multivariate regression analysis are pre-
sented in Table 4. The variables identified as the best predictive
variables for good quality of life (analyzing the physical and
psychosocial scores respectively) were altitude (coeffi-
cient = 9.574; 95% CI: 4.70–14.45 and coefficient = 24.383;
95% CI: 19.82–28.94 respectively) and degree of asthma sever-
ity (coefficient = 6.506; 95% CI: 8.60 to 4.41 and coeffi-
cient = 4.615; 95% CI: 6.58 to 2.65 respectively). The
models were significant and explained 32.2% (R2 = 0.322)
and 62.2% (R2 = 0.623) of the impact on patient quality of
life physical and psychosocial domains respectively.Discussion
To the best of our knowledge this is the first multicenter study
evaluating the effects of geo-climatic factors on the degree of
Table 4 Multivariate analysis predicting quality of life in the studied asthmatic children.
Predictors # Physical domain of PQL Psychosocial domain of PQL
ß (95% CI of ß) ß (95% CI of ß)
Asthma symptoms a 0.191 (2.71 – 3.09) 0.123 (2.59 – 2.84)
Controller medication b 0.359 (2.78 – 2.07) 1.148 (1.12 – 3.42)
Attitude c 9.574 (4.70 – 14.45) 24.383 (19.82 – 28.94)
Degree of asthma d 6.506 (8.60 – 4.41) 4.615 (6.58 – 2.65)
Allergenic asthma e 1.944 (1.61 – 5.50) 2.228 (1.10 – 5.55)
(Constant) 44.215 (27.87 – 60.56) 26.56 (11.259 – 41.86)
R2 32.20% 62.30%
F 13.79 50.64
P-values 0.001 0.001
# Age, sex, residence, socioeconomic standards, father education, father work were not included in the model because they were not significant
in univariate analysis.
a (Cough only = 1, cough and wheeze = 2, cough wheeze and dyspnea = 3).
b (No = 0, regular = 1, irregular = 2).
c (Low altitude = 1, moderate altitude = 2).
d (Intermittent = 0, mild = 1, moderate = 2, severe = 3).
e (Yes = 1, no = 2).
Pediatric asthma severity and quality of life 559asthma severity and quality of life among asthmatic pediatric
patients living at moderate and low altitudes in southwestern
Saudi Arabia.
The studied asthmatic patients living at low (Jizan) and
moderate (Abha) altitudes were matched in all sociodemo-
graphic criteria and managed according to the same principles
of Saudi Initiative for diagnosis and management of bronchial
asthma, 2012 [19]. However, the degree of disease severity was
significantly higher among low altitude patients compared to
moderate altitude. Also, complaining of dyspnea and the need
for regular use of corticosteroid controller medication were
reported more frequently among the former. It was evident
that, bronchial asthma is geno-environmental disease [20].
Among the environmental factors are the macro-
environmental characteristics such as geo-climatic differences.
In the International Study of Asthma and Allergies in
Childhood (ISAAC) that enrolled school children from 12
countries of Western Europe; altitude, annual variation of
temperature and outdoor humidity were negatively associated
with asthma symptoms [21]. Rijssenbeek-Nouwens and Bel
[22] and Massimo et al. [23] concluded in their review studies
the beneficial effects of moderate altitude on asthma symp-
toms, lung function, and corticosteroid requirements indepen-
dent of the atopic status in patients with severe refractory
asthma. Living in moderate altitude minimizes the severity of
bronchial asthma; these may be explained by the following:
house mites dust (HDM) allergen level decreases as altitude
increases, asthma control improves and specific HDM-IgE
level [24] and local airway inflammation are reduced during
a stay at high altitude [25]. Also, exposure to pollen is shorter
and lower at high altitude, which, in pollen-allergic patients,
accounts for a decrease in seasonal symptoms [26]. For non-
allergenic asthma, the levels of non-specific air pollutants such
as nitrogen oxides and particulate matter are much lower in
higher altitude compared to lower altitude. These could play
a major role in eliciting asthmatic symptoms, airway inflam-
mation, decreasing pulmonary function and medication
requirements [27].Other factors that could explain the higher disease severity,
symptoms and need for corticosteroid in low altitude (Jizan)
compared to moderate altitude (Abha) are the exposure to
higher average annual temperature (12 C more) and relative
outdoor humidity (5–20% more) in the former. It is possible
that higher temperatures and relative humidity are associated
with higher levels of allergens such as house dust mites, pollens
and molds [28,29].
The results of the current study indicate that quality of life
as measured by PedsQL correlated with degree of asthma
severity at both low and moderate altitudes. These were in
agreement with other study dealing with validation and relia-
bility of PedsQL questionnaire 18. These also were in accor-
dance with another study that concluded that bronchial
asthma can result in physical, emotional, and social limitations
for patients. These limitations can impair patient quality of life
in proportion to the degree of disease activity [30].
In the current study, the score of each domain of the quality
of life was significantly higher in patients living at moderate
altitude compared to those living at low altitude indicating a
better quality of life in moderate altitude asthmatic patients.
Moreover, the altitude was detected to be a significant inde-
pendent predictor for physical and psychosocial domains in
multivariate linear regression analysis. According to other
studies, the frequency of disease exacerbations and duration
of treatment became significantly lower in moderate to high
altitude compared to low altitude and consequently the quality
of life improved [22–26]. The discrepancy between the environ-
mental factors in moderate and low altitude may explain these
differences. Higher average annual temperature and humidity
at low altitude may contribute to more airway inflammation
in asthma and impairment in pulmonary functions due to fre-
quent perennial exposure to HDM allergen and fungi [28,29],
and higher levels of air pollution [27].
In conclusion, the results of the current study suggest that
the moderate altitude was significantly associated with a lower
degree of asthma disease severity, lower need for controller
medication and better quality of life.
560 A.S. Alsamghan et al.Study limitations
This was a convenience sample, and generalization is therefore
unwarranted. A larger national study is recommended to
assess the influence of geo-climatic diversity on pediatric
asthma severity and the associated quality of life. Another lim-
itation is related to the defect in correlating our results with the
objective assessment of the disease severity through measure-
ment of laboratory markers of airway inflammation.
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